ERBB2 and breast cancer: In modern practice, the course of treatment is dependent upon three subcategories of breast cancer that are defined by the presence or absence of specific molecular markers for estrogen or progesterone receptors and human epidermal growth factor 2 (ERBB2; formerly HER2) [3,4].